Shulamit Katzav

vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells.

Shulamit Katzav, Dionisio Martín‐Zanca, Mariano Barbacid · The EMBO Journal · 1989 · 516 citations

Hematopoietic Cells, Hematology, Blood Cell +5

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

Reinhard Wallich, Nadja Bulbuc, Günter J. Hämmerling et al. · Nature · 1985 · 409 citations

Tumor Biology, Cancer Immunosurveillance, Novo Expression +8

Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs

Ben Margolis, Patrick J Hu, Shulamit Katzav et al. · Nature · 1992 · 359 citations

Tyrosine Phosphorylation, Transcriptional Regulation, Viral Replication +11

Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations.

Giuseppe Cimino, Donald T. Moir, Ora Canaani et al. · PubMed · 1991 · 183 citations

Cytogenetics, Mixed-phenotype Acute Leukemia, Genetics +16

A Functional T-Cell Receptor Signaling Pathway Is Required for p95^<i>vav</i> Activity

Jun Wu, Shulamit Katzav, Arthur J. Weiss · Molecular and Cellular Biology · 1995 · 170 citations · Full text

Adaptive Immune System, T-regulatory Cell, Immune Regulation +21